TransCode Therapeutics Statistics
Total Valuation
RNAZ has a market cap or net worth of $7.46 million. The enterprise value is $2.88 million.
| Market Cap | 7.46M |
| Enterprise Value | 2.88M |
Important Dates
The next estimated earnings date is Tuesday, May 28, 2024, before market open.
| Earnings Date | May 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RNAZ has 6.57 million shares outstanding. The number of shares has increased by 27,557.71% in one year.
| Shares Outstanding | 6.57M |
| Shares Change (YoY) | +27,557.71% |
| Shares Change (QoQ) | +2,772.75% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 5.47% |
| Float | 6.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.63 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.48 |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -258.98 |
Financial Efficiency
Return on equity (ROE) is -534.80% and return on invested capital (ROIC) is -361.65%.
| Return on Equity (ROE) | -534.80% |
| Return on Assets (ROA) | -238.80% |
| Return on Capital (ROIC) | -361.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.71M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.53% in the last 52 weeks. The beta is -0.36, so RNAZ's price volatility has been lower than the market average.
| Beta (1Y) | -0.36 |
| 52-Week Price Change | -99.53% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 15.24 |
| Relative Strength Index (RSI) | 59.68 |
| Average Volume (30 Days) | 1,076,390 |
Short Selling Information
The latest short interest is 149,637, so 2.28% of the outstanding shares have been sold short.
| Short Interest | 149,637 |
| Short Previous Month | 18,555 |
| Short % of Shares Out | 2.28% |
| Short % of Float | 2.40% |
| Short Ratio (days to cover) | 0.32 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.81M |
| Pretax Income | -17.06M |
| Net Income | -17.06M |
| EBITDA | -16.43M |
| EBIT | -16.99M |
| Earnings Per Share (EPS) | -$229.08 |
Balance Sheet
The company has $4.91 million in cash and $339,408 in debt, giving a net cash position of $4.57 million or $0.70 per share.
| Cash & Cash Equivalents | 4.91M |
| Total Debt | 339,408 |
| Net Cash | 4.57M |
| Net Cash Per Share | $0.70 |
| Equity / Book Value | 4.58M |
| Book Value Per Share | 0.70 |
| Working Capital | 4.01M |
Cash Flow
In the last 12 months, operating cash flow was -$17.50 million and capital expenditures -$26,549, giving a free cash flow of -$17.52 million.
| Operating Cash Flow | -17.50M |
| Capital Expenditures | -26,549 |
| Free Cash Flow | -17.52M |
| FCF Per Share | -$3.41 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RNAZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27,557.71% |
| Shareholder Yield | -27,557.71% |
| Earnings Yield | -228.72% |
| FCF Yield | -235.01% |
Analyst Forecast
The average price target for RNAZ is $3.00, which is 160.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 160.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -66.48% |
Stock Splits
The last stock split was on January 16, 2024. It was a reverse split with a ratio of 1:40.
| Last Split Date | Jan 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |